The New England journal of medicine, 2018-09, Vol.379 (10), p.934-947
- Morschhauser, Franck
- Fowler, Nathan H
- Feugier, Pierre
- Bouabdallah, Reda
- Tilly, Hervé
- Palomba, M. Lia
- Fruchart, Christophe
- Libby, Edward N
- Casasnovas, Rene-Olivier
- Flinn, Ian W
- Haioun, Corinne
- Maisonneuve, Hervé
- Ysebaert, Loic
- Bartlett, Nancy L
- Bouabdallah, Kamal
- Brice, Pauline
- Ribrag, Vincent
- Daguindau, Nicolas
- Le Gouill, Steven
- Pica, Gian M
- Martin Garcia-Sancho, Alejandro
- López-Guillermo, Armando
- Larouche, Jean-François
- Ando, Kiyoshi
- Gomes da Silva, Maria
- André, Marc
- Zachée, Pierre
- Sehn, Laurie H
- Tobinai, Kensei
- Cartron, Guillaume
- Liu, David
- Wang, Jianming
- Xerri, Luc
- Salles, Gilles A
2018
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Morschhauser, Franck
- Fowler, Nathan H
- Feugier, Pierre
- Bouabdallah, Reda
- Tilly, Hervé
- Palomba, M. Lia
- Fruchart, Christophe
- Libby, Edward N
- Casasnovas, Rene-Olivier
- Flinn, Ian W
- Haioun, Corinne
- Maisonneuve, Hervé
- Ysebaert, Loic
- Bartlett, Nancy L
- Bouabdallah, Kamal
- Brice, Pauline
- Ribrag, Vincent
- Daguindau, Nicolas
- Le Gouill, Steven
- Pica, Gian M
- Martin Garcia-Sancho, Alejandro
- López-Guillermo, Armando
- Larouche, Jean-François
- Ando, Kiyoshi
- Gomes da Silva, Maria
- André, Marc
- Zachée, Pierre
- Sehn, Laurie H
- Tobinai, Kensei
- Cartron, Guillaume
- Liu, David
- Wang, Jianming
- Xerri, Luc
- Salles, Gilles A
- Titel
- Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma
- Ist Teil von
- The New England journal of medicine, 2018-09, Vol.379 (10), p.934-947
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2018
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- The combination of rituximab and lenalidomide achieved results that were similar to those of rituximab plus chemotherapy in the treatment of previously untreated patients with advanced follicular lymphoma.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793eISSN: 1533-4406DOI: 10.1056/NEJMoa1805104Titel-ID: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11003525
- Format
- –
- Schlagworte
- Adult, Advisors, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols - adverse effects, Antineoplastic Combined Chemotherapy Protocols - therapeutic use, Apoptosis, Cancer, Chemotherapy, Clinical medicine, Disease-Free Survival, Fees & charges, Female, Humans, Immunomodulation, Immunotherapy, Intention to Treat Analysis, Lenalidomide, Life Sciences, Lymphocytes B, Lymphoma, Lymphoma, Follicular - drug therapy, Lymphoma, Follicular - mortality, Male, Middle Aged, Monoclonal antibodies, Neutropenia, Neutropenia - chemically induced, Patients, Rituximab, Rituximab - administration & dosage, Rituximab - adverse effects, Skin Diseases - chemically induced, Survival Rate, Targeted cancer therapy, Thalidomide - administration & dosage, Thalidomide - adverse effects, Thalidomide - analogs & derivatives